Abstract
Aim: To examine whether lysophosphatidic acid (LPA) induces phosphorylation of c-Met and epidermal growth factor receptor (EGFR), both of which have been proposed as prognostic markers of colorectal cancer, and whether LPA induces cyclooxygenase-2 (COX-2) expression in human colon cancer cells. Methods: Using a human colon cancer cell line, LoVo cells, we performed immunoprecipitation analysis, followed by Western blot analysis. We also examined whether LPA induced COX-2 expression, by Western blot analysis. Results: Immunoprecipitation analysis revealed that 10 μmol/L LPA induced tyrosine phosphorylation of c-Met and EGFR in LoVo cells within a few minutes. We found that c-Met tyrosine phosphorylation induced by LPA was not attenuated by pertussis toxin or a matrix metalloproteinase inhibitor, in marked contrast to the results for EGFR. In addition, 0.2-40 μmol/L LPA induced COX-2 expression in a dose-dependent manner. Conclusion: Our results suggest that LPA acts upstream of various receptor tyrosine kinases (RTKs) and COX-2, and thus may act as a potent stimulator of colorectal cancer. © 2005 The WJG Press and Elsevier Inc. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Shida, D., Kitayama, J., Yamaguchi, H., Yamashita, H., Mori, K., Watanabe, T., & Nagawa, H. (2005). Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cylooxygenase-2 expression in human colon cancer LoVo cells. World Journal of Gastroenterology, 11(36), 5638–5643. https://doi.org/10.3748/wjg.v11.i36.5638
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.